痛风活动评分具有预测效度且对变化敏感:诺丁汉痛风治疗试验(II期)结果
本研究基于诺丁汉痛风治疗试验(II期)数据,检验痛风活动评分(GAS)的预测效度、与痛风影响量表(GIS)的相关性及对变化的敏感性。结果显示GAS与GIS的痛风总体担忧和未满足治疗需求子量表呈低度正相关(r=0.34-0.45),GAS是所考察结局指标中对变化最敏感的(SRM 0.89至-0.53),且基线GAS独立关联未来12个月频繁发作。结论认为GAS对变化敏感、具有预测效度,但在临床采用前仍需额外独立验证。
要点
- GAS与GIS的痛风总体担忧和未满足治疗需求子量表呈低度正相关(r=0.34-0.45)。
- GAS是所考察结局指标中对变化最敏感的(SRM 0.89至-0.53)。
- 基线GAS独立关联未来12个月频繁痛风发作,但临床采用前仍需独立验证。
核心结论
- GAS对变化敏感、具有预测效度,并与GIS的痛风总体担忧等相关域相关,但临床采用前仍需额外独立验证。
研究设计与样本
- 基于一项临床试验数据,参与者为既往一年内至少有一次痛风发作、从初级保健招募并随机接受护士主导或继续常规照护的患者。
- 计算GAS和GIS,评分越高分别表示疾病活动度和生活质量越差;用Spearman相关分析GAS与GIS的相关性。
- 计算标准化反应均值(SRM)评估对变化的敏感性;用Poisson回归评估基线GAS与未来12个月发作次数的关联。
- 数据分析使用STATA版本14,P值<0.05为有统计学意义。
主要发现
- GAS与GIS的痛风总体担忧和未满足治疗需求子量表呈低度正相关(r=0.34-0.45)。
- 女性与较少痛风发作独立相关,而GAS升高、BMI和年龄增加与频繁发作独立相关。
- 在所考察的所有结局指标中,GAS对变化最敏感(SRM 0.89至-0.53)。
- 在GIS各域中,痛风总体担忧域对变化敏感性最佳(SRM 1.06至-0.01)。
关键数值与推荐
- GAS与GIS的痛风总体担忧和未满足治疗需求子量表相关系数r=0.34-0.45。
- GAS的SRM范围为0.89至-0.53;GIS痛风总体担忧域的SRM范围为1.06至-0.01。
临床怎么用
- GAS可用于评估痛风疾病活动度并预测未来发作风险,但原文强调在临床采用前仍需额外独立验证。
局限性
- 原文未报告具体局限性描述;结论指出GAS在临床采用前仍需额外独立验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To examine the predictive validity of the Gout Activity Score (GAS), its correlation with the Gout Impact Scale (GIS) and their sensitivity to change. METHODS: Data from a clinical trial in which participants with one or more gout flares in the previous year were recruited from primary care and randomized to nurse-led or continuing usual care were used in this study. GAS and GIS were calculated as described, with higher scores indicating worse disease activity and quality of life, respectively. The correlation between GAS and GIS was examined using Spearman's correlation. Standardized response means (SRMs) were calculated to assess sensitivity to change. The association between GAS at baseline and the number of flares in the next 12 months was evaluated using Poisson regression. Data analyses were performed using STATA version 14, with P-values <0.05 being statistically significant. RESULTS: There was low positive correlation between GAS and gout concern overall and unmet treatment need subscales of GIS (r = 0.34-0.45). Female sex associated independently with fewer gout flares, while increasing GAS, BMI and age associated independently with frequent flares. Of all the outcome measures examined, GAS was the most responsive to change (SRM 0.89 to -0.53). Of the GIS domains, the gout concern overall domain had the best sensitivity to change (SRM 1.06-0.01). CONCLUSION: GAS is sensitive to change, has predictive validity and correlates with relevant domains of GIS such as gout concern overall. Additional independent validation of GAS is required before it can be adopted in clinical practice.
引用
- Chinchilla SP, Doherty M, Abhishek A, et al. Gout Activity Score has predictive validity and is sensitive to change: results from the Nottingham Gout Treatment Trial (Phase II). Rheumatology (Oxford). 2019. PMID: 30726962. doi:10.1093/rheumatology/key446
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。